Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 462

1.

Pre-clinical development of U3-1784, a novel FGFR4 antibody against cancer, and avoidance of its on-target toxicity.

Bartz R, Fukuchi K, Ohtsuka T, Lange T, Gruner K, Watanabe I, Hayashi S, Oda Y, Kawaida R, Komori H, Kashimoto Y, Wirtz P, Mayer JA, Redondo-Müller M, Saito S, Takahashi M, Hanzawa H, Imai E, Martinez A, Hanai M, Häussinger D, Chapman RW, Agatsuma T, Bange J, Abraham R.

Mol Cancer Ther. 2019 Jul 26. pii: molcanther.0048.2018. doi: 10.1158/1535-7163.MCT-18-0048. [Epub ahead of print]

PMID:
31350344
2.

Performance of GFR Slope as a Surrogate Endpoint for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.

Greene T, Ying J, Vonesh EF, Tighiouart H, Levey AS, Coresh J, Herrick JS, Imai E, Jafar TH, Maes BD, Perrone RD, Del Vecchio L, Wetzels JFM, Heerspink HJL, Inker LA.

J Am Soc Nephrol. 2019 Jul 10. pii: ASN.2019010009. doi: 10.1681/ASN.2019010009. [Epub ahead of print]

PMID:
31292198
3.

A Body Mass Index-Based Cross-Classification Approach for the Assessment of Prognostic Factors in Chronic Kidney Disease Progression.

Kataoka H, Ono K, Mochizuki T, Hanafusa N, Imai E, Hishida A, Nitta K.

Kidney Blood Press Res. 2019;44(3):362-383. doi: 10.1159/000501021. Epub 2019 Jun 14.

4.

Fish and meat intakes and prevalence of anemia among the Japanese elderly.

Imai E, Nakade M.

Asia Pac J Clin Nutr. 2019;28(2):276-284. doi: 10.6133/apjcn.201906_28(2).0010.

5.

Immunology of membranous nephropathy.

Akiyama S, Imai E, Maruyama S.

F1000Res. 2019 May 24;8. pii: F1000 Faculty Rev-734. doi: 10.12688/f1000research.17589.1. eCollection 2019. Review.

6.

Analysis of 2897 hospitalization events for patients with chronic kidney disease: results from CKD-JAC study.

Iimuro S, Kaneko T, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators.

Clin Exp Nephrol. 2019 Jul;23(7):956-968. doi: 10.1007/s10157-019-01730-9. Epub 2019 Apr 9.

7.

Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events.

Suzuki A, Obi Y, Hayashi T, Kotani N, Uemura Y, Imai E, Makino H, Hishida A.

Clin Exp Nephrol. 2019 May;23(5):661-668. doi: 10.1007/s10157-019-01695-9. Epub 2019 Jan 28.

8.

Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.

Tanaka T, Nangaku M, Imai E, Tsubakihara Y, Kamai M, Wada M, Asada S, Akizawa T.

Clin Exp Nephrol. 2019 Mar;23(3):435. doi: 10.1007/s10157-019-01694-w.

PMID:
30673934
9.

Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.

Minagawa A, Yoshikawa T, Yasukawa M, Hotta A, Kunitomo M, Iriguchi S, Takiguchi M, Kassai Y, Imai E, Yasui Y, Kawai Y, Zhang R, Uemura Y, Miyoshi H, Nakanishi M, Watanabe A, Hayashi A, Kawana K, Fujii T, Nakatsura T, Kaneko S.

Cell Stem Cell. 2018 Dec 6;23(6):850-858.e4. doi: 10.1016/j.stem.2018.10.005. Epub 2018 Nov 15.

PMID:
30449714
10.

Sleep Quality and Sleep Duration with CKD are Associated with Progression to ESKD.

Yamamoto R, Shinzawa M, Isaka Y, Yamakoshi E, Imai E, Ohashi Y, Hishida A; CKD-JAC Investigators.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1825-1832. doi: 10.2215/CJN.01340118. Epub 2018 Nov 15.

PMID:
30442866
11.

Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.

Yabe M, Koike T, Ohtsubo K, Imai E, Morimoto T, Takakura H, Koh K, Yoshida K, Ogawa S, Ito E, Okuno Y, Muramatsu H, Kojima S, Matsuo K, Mori M, Hira A, Takata M, Yabe H.

Ann Hematol. 2019 Feb;98(2):271-280. doi: 10.1007/s00277-018-3517-0. Epub 2018 Oct 27.

PMID:
30368588
12.

Environmental Data and Survival Data of Deinococcus aetherius from the Exposure Facility of the Japan Experimental Module of the International Space Station Obtained by the Tanpopo Mission.

Yamagishi A, Kawaguchi Y, Hashimoto H, Yano H, Imai E, Kodaira S, Uchihori Y, Nakagawa K.

Astrobiology. 2018 Nov;18(11):1369-1374. doi: 10.1089/ast.2017.1751. Epub 2018 Oct 5.

PMID:
30289276
13.

Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.

Tanaka T, Nangaku M, Imai E, Tsubakihara Y, Kamai M, Wada M, Asada S, Akizawa T.

Clin Exp Nephrol. 2019 Feb;23(2):231-243. doi: 10.1007/s10157-018-1632-9. Epub 2018 Sep 4. Erratum in: Clin Exp Nephrol. 2019 Jan 23;:.

14.

Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.

Maruta Y, Hasegawa T, Yamakoshi E, Nishiwaki H, Koiwa F, Imai E, Hishida A.

Clin Exp Nephrol. 2019 Feb;23(2):215-222. doi: 10.1007/s10157-018-1631-x. Epub 2018 Aug 24.

15.

Correction to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2019 Jan;23(1):99. doi: 10.1007/s10157-018-1624-9.

PMID:
30094596
16.

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2019 Jan;23(1):85-98. doi: 10.1007/s10157-018-1605-z. Epub 2018 Jun 27. Erratum in: Clin Exp Nephrol. 2018 Aug 9;:.

17.

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.

Clin Exp Nephrol. 2018 Dec;22(6):1266-1280. doi: 10.1007/s10157-018-1579-x. Epub 2018 Apr 20.

PMID:
29679356
18.
19.

Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study.

Kawamura T, Usui J, Kaneko S, Tsunoda R, Imai E, Kai H, Morito N, Saito C, Nagata M, Yamagata K.

BMC Nephrol. 2017 Nov 25;18(1):337. doi: 10.1186/s12882-017-0754-8.

20.

An objective evaluation of nocturnal cough count and cough pattern in children with psychogenic cough.

Imai E, Hirai K, Mikami Y, Nukaga M, Enseki M, Tabata H, Kato M, Mochizuki H.

Respir Investig. 2017 Nov;55(6):334-337. doi: 10.1016/j.resinv.2017.08.008. Epub 2017 Oct 21. Review.

PMID:
29153413
21.

Retraction Note to: Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.

Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.

Clin Exp Nephrol. 2017 Dec;21(6):1146. doi: 10.1007/s10157-017-1466-x. No abstract available.

PMID:
28889397
22.

Erratum to: Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):85-86. doi: 10.1007/s10157-017-1461-2. No abstract available.

PMID:
28875480
23.

A lung sound analysis in a child thought to have cough variant asthma: A case report.

Imai E, Enseki M, Nukaga M, Tabata H, Hirai K, Kato M, Mochizuki H.

Allergol Int. 2018 Jan;67(1):150-152. doi: 10.1016/j.alit.2017.06.004. Epub 2017 Jun 30. No abstract available.

24.

Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial).

Kato H, Nangaku M, Hirakata H, Wada T, Hayashi T, Sato H, Yamazaki Y, Masaki T, Kagimura T, Yamamoto H, Hase H, Kamouchi M, Imai E, Mizuno K, Iwasaki M, Akizawa T, Tsubakihara Y, Maruyama S, Narita I.

Clin Exp Nephrol. 2018 Feb;22(1):78-84. doi: 10.1007/s10157-017-1427-4. Epub 2017 Jun 28. Erratum in: Clin Exp Nephrol. 2017 Sep 5;:.

25.
26.

Different Psychosocial Factors Are Associated With Different Intention and Self-Efficacy Toward Eating Breakfast Among Japanese Breakfast Skippers.

Nakade M, Tsubota-Utsugi M, Imai E, Tsuboyama-Kasaoka N, Nishi N, Takimoto H.

Asia Pac J Public Health. 2017 Mar;29(2):102-113. doi: 10.1177/1010539517691092. Epub 2017 Feb 15.

PMID:
28201941
27.

Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.

Sakata F, Ito Y, Mizuno M, Sawai A, Suzuki Y, Tomita T, Tawada M, Tanaka A, Hirayama A, Sagara A, Wada T, Maruyama S, Soga T, Matsuo S, Imai E, Takei Y.

Lab Invest. 2017 Apr;97(4):432-446. doi: 10.1038/labinvest.2017.4. Epub 2017 Feb 6.

28.
29.

Cardiovascular events and death in Japanese patients with chronic kidney disease.

Tanaka K, Watanabe T, Takeuchi A, Ohashi Y, Nitta K, Akizawa T, Matsuo S, Imai E, Makino H, Hishida A; CKD-JAC Investigators.

Kidney Int. 2017 Jan;91(1):227-234. doi: 10.1016/j.kint.2016.09.015. Epub 2016 Nov 22.

30.

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.

Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group.

Clin Exp Nephrol. 2017 Dec;21(6):961-970. doi: 10.1007/s10157-016-1340-2. Epub 2016 Oct 25.

31.

Clinical practice guideline for drug-induced kidney injury in Japan 2016: digest version.

Usui J, Yamagata K, Imai E, Okuyama H, Kajiyama H, Kanamori H, Kaneko S, Kono E, Sakai Y, Sakai N, Sakamaki Y, Taniguchi Y, Nakai K, Nishiwaki H, Hirata S, Yamaya H, Tsuruoka S, Terada Y, Yokoyama H, Wada T, Narita I.

Clin Exp Nephrol. 2016 Dec;20(6):827-831. doi: 10.1007/s10157-016-1334-0. Review. No abstract available.

32.

The physical examination content of the Japanese National Health and Nutrition Survey: temporal changes.

Tanaka H, Imai S, Nakade M, Imai E, Takimoto H.

Asia Pac J Clin Nutr. 2016 Dec;25(4):898-910. doi: 10.6133/apjcn.092015.34.

33.

Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate.

Matsushita K, Chen J, Sang Y, Ballew SH, Shimazaki R, Fukagawa M, Imai E, Coresh J, Hishida A.

Kidney Int. 2016 Nov;90(5):1109-1114. doi: 10.1016/j.kint.2016.08.003. Epub 2016 Sep 22.

PMID:
27666758
34.

Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.

Inaguma D, Imai E, Takeuchi A, Ohashi Y, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Hishida A; Chronic Kidney Disease Japan Cohort Study Group.

Clin Exp Nephrol. 2017 Jun;21(3):446-456. doi: 10.1007/s10157-016-1309-1. Epub 2016 Jul 13.

35.

A novel heterozygous mutation in the ATP6V0A4 gene encoding the V-ATPase a4 subunit in an adult patient with incomplete distal renal tubular acidosis.

Imai E, Kaneko S, Mori T, Okado T, Uchida S, Tsukamoto Y.

Clin Kidney J. 2016 Jun;9(3):424-8. doi: 10.1093/ckj/sfw008. Epub 2016 Mar 24. Erratum in: Clin Kidney J. 2016 Dec;9(6):871.

36.

Vascular Endothelial Cell Injury Is an Important Factor in the Development of Encapsulating Peritoneal Sclerosis in Long-Term Peritoneal Dialysis Patients.

Tawada M, Ito Y, Hamada C, Honda K, Mizuno M, Suzuki Y, Sakata F, Terabayashi T, Matsukawa Y, Maruyama S, Imai E, Matsuo S, Takei Y.

PLoS One. 2016 Apr 27;11(4):e0154644. doi: 10.1371/journal.pone.0154644. eCollection 2016.

37.

In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy.

Serino G, Pesce F, Sallustio F, De Palma G, Cox SN, Curci C, Zaza G, Lai KN, Leung JC, Tang SC, Papagianni A, Stangou M, Goumenos D, Gerolymos M, Takahashi K, Yuzawa Y, Maruyama S, Imai E, Schena FP.

Kidney Int. 2016 Mar;89(3):683-92.

PMID:
26581012
38.

Is the new GFR equation using inulin clearance a more accurate method for Asian patients?

Kim BS, Lee YK, Choi HY, Choi SO, Shin SK, Ha SK, Lee KW, Kim YW, Kim YL, Yasuda Y, Imai E, Horio M, Tomino Y, Matsuo S, Lee HY.

Clin Nephrol. 2015 Dec;84(6):331-8. doi: 10.5414/CN108496.

PMID:
26558368
39.

A Prospective Observational Survey on the Long-Term Effect of LDL Apheresis on Drug-Resistant Nephrotic Syndrome.

Muso E, Mune M, Hirano T, Hattori M, Kimura K, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Takemura T, Yuzawa Y, Ogahara S, Sugiyama S, Iino Y, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Imai E, Matsuo S, Saito T.

Nephron Extra. 2015 Aug 29;5(2):58-66. doi: 10.1159/000437338. eCollection 2015 May-Aug.

40.

Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.

Kitamura M, Akamatsu M, Kawanami M, Furuichi Y, Fujii T, Mori M, Kunimatsu K, Shimauchi H, Ogata Y, Yamamoto M, Nakagawa T, Sato S, Ito K, Ogasawara T, Izumi Y, Gomi K, Yamazaki K, Yoshie H, Fukuda M, Noguchi T, Takashiba S, Kurihara H, Nagata T, Hamachi T, Maeda K, Yokota M, Sakagami R, Hara Y, Noguchi K, Furuuchi T, Sasano T, Imai E, Ohmae M, Koizumi H, Watanuki M, Murakami S.

J Bone Miner Res. 2016 Apr;31(4):806-14. doi: 10.1002/jbmr.2738. Epub 2015 Dec 6.

41.

Mice doubly-deficient in the Arf GAPs SMAP1 and SMAP2 exhibit embryonic lethality.

Sumiyoshi M, Masuda N, Tanuma N, Ogoh H, Imai E, Otsuka M, Hayakawa N, Ohno K, Matsui Y, Hara K, Gotoh R, Suzuki M, Rai S, Tanaka H, Matsumura I, Shima H, Watanabe T.

FEBS Lett. 2015 Sep 14;589(19 Pt B):2754-62. doi: 10.1016/j.febslet.2015.07.050. Epub 2015 Aug 18.

42.

Genome-wide association study of IgA nephropathy using 23 465 microsatellite markers in a Japanese population.

Saka S, Hirawa N, Oka A, Yatsu K, Hirukawa T, Yamamoto R, Matsusaka T, Imai E, Narita I, Endoh M, Ichikawa I, Umemura S, Inoko H.

J Hum Genet. 2015 Oct;60(10):573-80. doi: 10.1038/jhg.2015.88. Epub 2015 Jul 23.

PMID:
26202575
43.

Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure).

Imai E, Ito S, Haneda M, Harada A, Kobayashi F, Yamasaki T, Makino H, Chan JC.

Nephrol Dial Transplant. 2016 Mar;31(3):447-54. doi: 10.1093/ndt/gfv272. Epub 2015 Jul 6.

44.

Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury.

Terabayashi T, Ito Y, Mizuno M, Suzuki Y, Kinashi H, Sakata F, Tomita T, Iguchi D, Tawada M, Nishio R, Maruyama S, Imai E, Matsuo S, Takei Y.

Lab Invest. 2015 Sep;95(9):1029-43. doi: 10.1038/labinvest.2015.87. Epub 2015 Jun 29.

45.

Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial).

Imai E, Maruyama S, Nangaku M, Hirakata H, Hayashi T, Narita I, Kono H, Nakatani E, Morita S, Tsubakihara Y, Akizawa T.

Clin Exp Nephrol. 2016 Feb;20(1):71-6. doi: 10.1007/s10157-015-1133-z. Epub 2015 Jun 17.

PMID:
26081567
46.

A case of acute interstitial nephritis and granulomatous hepatitis induced by ingesting quinine.

Katsuma A, Shibata M, Katsuki T, Imai E, Tada M, Hinoshita F.

CEN Case Rep. 2015 May;4(1):76-80. doi: 10.1007/s13730-014-0143-0. Epub 2014 Aug 29.

47.

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.

Kato S, Maruyama S, Makino H, Wada J, Ogawa D, Uzu T, Araki H, Koya D, Kanasaki K, Oiso Y, Goto M, Nishiyama A, Kobori H, Imai E, Ando M, Matsuo S.

Clin Exp Nephrol. 2015 Dec;19(6):1098-106. doi: 10.1007/s10157-015-1106-2. Epub 2015 Mar 21.

48.

Silica aerogel for capturing intact interplanetary dust particles for the Tanpopo experiment.

Tabata M, Yano H, Kawai H, Imai E, Kawaguchi Y, Hashimoto H, Yamagishi A.

Orig Life Evol Biosph. 2015 Jun;45(1-2):225-9. doi: 10.1007/s11084-015-9423-8. Epub 2015 Mar 21.

PMID:
25794831
49.

Difficulty with cuff deflation of reinforced tracheal tube caused by inflation line occlusion with silk thread ligation and fixation.

Gotoh S, Sugiyama D, Imai E, Kawamata M.

BMJ Case Rep. 2015 Mar 5;2015. pii: bcr2014207933. doi: 10.1136/bcr-2014-207933.

50.

Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese.

Hayashi N, Akiyama S, Okuyama H, Matsui Y, Adachi H, Yamaya H, Maruyama S, Imai E, Matsuo S, Yokoyama H.

Clin Exp Nephrol. 2015 Oct;19(5):797-803. doi: 10.1007/s10157-014-1064-0. Epub 2014 Dec 10.

PMID:
25492250

Supplemental Content

Support Center